Association between urokinase haplotypes and outcome from infection-associated acute lung injury

Intensive Care Medicine

Volumn 34, Issue 2, 2008, Pages 300-307

  Arcaroli, John ^a   Sankoff, Jeff ^a   Liu, Nianjun ^b   Allison, David B ^b   Maloney, James ^a   Abraham, Edward ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Acute lung injury; Genetics; Haplotypes; Polymorphisms; Sepsis; Urokinase

Indexed keywords

UROKINASE;

ACUTE LUNG INJURY; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; INFECTION; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TIDAL VOLUME; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUROPE; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UNITED STATES; URINARY PLASMINOGEN ACTIVATOR;

EID: 39149140713     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0930-6     Document Type: Article

References (51)

1. Bernard GR (2005) Acute respiratory distress syndrome: a historical perspective. Am J Respir Crit Care Med 172:798-806
2. Matthay MA, Zimmerman GA (2005) Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 33:319-327
3. Ware LB, Camerer E, Welty-Wolf K, Schultz MJ, Matthay MA (2006) Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. Am J Physiol Lung Cell Mol Physiol 291:L307-L311
4. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD (2007) Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 35:1821-1828
5. Blasi F, Carmeliet P (2002) uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3:932-943
6. Idell S (2002) Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways. Crit Care Med 30:S274-S280
7. Abraham E, Gyetko MR, Kuhn K, Arcaroli J, Strassheim D, Park JS, Shetty S, Idell S (2003) Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J Immunol 170:5644-5651
8. van der Poll T, Levi M, Nick JA, Abraham E (2005) Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am J Respir Crit Care Med 171:1125-1128
9. Levi M, Schultz MJ, Rijneveld AW, van der Poll T (2003) Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 31:S238-S242
10. Choi G, Schultz MJ, van Till JW, Bresser P, van der Zee JS, Boermeester MA, Levi M, van der Poll T (2004) Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J 24:786-789
11. Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS (2006) Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia: a review. Crit Care Med 34:871-877
12. Groeneveld AB, Kindt I, Raijmakers PG, Hack CE, Thijs LG (1997) Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome. Thromb Haemost 78:1444-1449
13. Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA (2003) Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 285:L20-L28
14. Idell S (2003) Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 31:S213-S220
15. El Solh AA, Bhora M, Pineda L, Aquilina A, Abbetessa L, Berbary E (2006) Alveolar plasminogen activator inhibitor-1 predicts ARDS in aspiration pneumonitis. Intensive Care Med 32:110-115
16. Wang XQ, Bdeir K, Yarovoi S, Cines DB, Fang W, Abraham E (2006) Involvement of the urokinase kringle domain in lipopolysaccharide-induced acute lung injury. J Immunol 177:5550-5557
17. Kwak S-H, Mitra S, Bdeir K, Strassheim D, Park JS, Kim JK, Idell S, Cines DL, Abraham E (2005) The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins. J Leukoc Biol 78:937-945
18. Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y (1999) The plasminogen activator system: biology and regulation. Cell Mol Life Sci 56:104-132
19. Przybylowska K, Smolarczyk K, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Blasiak J (2002). Antigen levels of the urokinase-type plasminogen activator and its gene polymorphisms in colorectal cancer. Cancer Lett 181:23-30
20. Majsterek I, Przybylowska K, Mlynarski W, Drzewoski J, Blasiak J (2005) Distribution of C->T and T->C polymorphisms of the urokinase-type plasminogen activator gene in children with type 1 diabetes mellitus and insulin resistance. Clin Exp Med 4:202-206
21. Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, Hella M, Jain S, Hackett A, Scanlin L, Kelly J, Kihiko-Ehman M, Neltner M, Hersh L, Kindy M, Markesbery W, Hutton M, de Andrade M, Petersen RC, Graff-Radford N, Estus S, Brookes AJ, Younkin SG (2005) Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Hum Mol Genet 14:447-460
22. Riemenschneider M, Konta L, Friedrich P, Schwarz S, Taddei K, Neff F, Padovani A, Kolsch H, Laws SM, Klopp N, Bickeboller H, Wagenpfeil S, Mueller JC, Rosenberger A, Diehl-Schmid J, Archetti S, Lautenschlager N, Borroni B, Muller U, Illig T, Heun R, Egensperger R, Schlegel J, Forstl H, Martins RN, Kurz A (2006) A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease. Hum Mol Genet 15:2446-2456
23. Huang CM, Chen CL, Tsai JJ, Tsai CH, Tsai FJ (2004) Association between urokinase gene 3'-UTR T/C polymorphism and Chinese patients with rheumatoid arthritis in Taiwan. Clin Exp Rheumatol 22:219-222
24. Begin P, Tremblay K, Daley D, Lemire M, Claveau S, Salesse C, Kacel S, Montpetit A, Becker A, Chan-Yeung M, Kozyrskyj AL, Hudson TJ, Laprise C (2007) Association of urokinase-type plasminogen activator with asthma and atopy. Am J Respir Crit Care Med 175:1109-1116
25. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327-336
26. Scheet P, Stephens M (2006) A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 78:629-644
27. Zhao J, Jin L, Xiong M (2006) Test for interaction between two unlinked loci. Am J Hum Genet 79:831-845
28. Zhao J, Jin L, Xiong M (2006) Nonlinear tests for genomewide association studies. Genetics 174:1529-1538
29. Zhao JY, Xiong MM, Huang W, Wang H, Zuo J, Wu GD, Chen Z, Qiang BQ, Zhang ML, Chen JL, Ding W, Yuan WT, Xu HY, Jin L, Li YX, Sun Q, Liu QY, Boerwinkle E, Fang FD (2005) An autosomal genomic scan for loci linked to type 2 diabetes in northern Han Chinese. J Mol Med 83:209-215
30. Lin DY, Zeng D, Millikan R (2005) Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol 29:299-312
31. Zeng D, Lin DY (2005) Estimating haplotype-disease associations with pooled genotype data. Genet Epidemiol 28:70-82
32. Zeng D, Lin DY, Avery CL, North KE, Bray MS (2006) Efficient semiparametric estimation of haplotype-disease associations in case-cohort and nested case-control studies. Biostatistics 7:486-502
33. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434
34. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ (2003) Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 55:56-65
35. Guo SW, Thompson EA (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361-372
36. Myers AJ, Marshall H, Holmans P, Compton D, Crook RJ, Mander AP, Nowotny P, Smemo S, Dunstan M, Jehu L, Wang JC, Hamshere M, Morris JC, Norton J, Chakraventy S, Tunstall N, Lovestone S, Petersen R, O'Donovan M, Jones L, Williams J, Owen MJ, Hardy J, Goate A (2004) Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD. Am J Med Genet B Neuropsychiatr Genet 124:29-37
37. Manocha S, Russell JA, Sutherland AM, Wattanathum A, Walley KR (2007) Fibrinogen-beta gene haplotype is associated with mortality in sepsis. J Infect 54:572-577
38. Arcaroli J, Fessler MB, Abraham E (2005) Genetic polymorphisms and sepsis. Shock 24:300-312
39. Maris NA, de Vos AF, Bresser P, van der Zee JS, Meijers JC, Lijnen HR, Levi M, Jansen HM, van der Poll T (2005) Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb Haemost 93:1036-1040
40. Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T (2004) Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 59:130-135
41. Rijneveld AW, Weijer S, Bresser P, Florquin S, Vlasuk GP, Rote WE, Spek CA, Reitsma PH, van der Zee JS, Levi M, van der Poll T (2006) Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med 34:1725-1730
42. Idell S (1994) Extravascular coagulation and fibrin deposition in acute lung injury. New Horiz 2:566-574
43. Abraham E (2000) Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 22:401-404
44. Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W (2000) Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161:454-462
45. Ware LB, Bastarache JA, Wang L (2005) Coagulation and fibrinolysis in human acute lung injury: new therapeutic targets? Keio J Med 54:142-149
46. Gyetko MR, Sitrin RG, Fuller JA, Todd RF, Petty H, Standiford TJ (1995) Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukoc Biol 58:533-538
47. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F (1996) Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. Embo J 15:1572-1582
48. Mondino A, Resnati M, Blasi F (1999) Structure and function of the urokinase receptor. Thromb Haemost [Suppl 1] 82:19-22
49. Sitrin RG, Pan PM, Blackwood RA, Huang J Petty HR (2001) Cutting edge: evidence for a signaling partnership between urokinase receptors (CD87) and L-selectin (CD62L) in human polymorphonuclear neutrophils. J Immunol 166:4822-4825
50. Shetty S, Bdeir K, Cines DB, Idell S (2003) Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem 278:18124-18131
51. Reuning U, Magdolen V, Hapke S, Schmitt M (2003) Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Biol Chem 384:1119-1131